KALA BIO, Inc.
KALA
$9.31
$0.536.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.85% | 9.86% | 8.74% | 16.06% | -348.22% |
| Total Depreciation and Amortization | -3.26% | -10.62% | -14.52% | -16.93% | -28.31% |
| Total Amortization of Deferred Charges | -21.47% | -9.22% | -0.40% | 2.02% | 5.23% |
| Total Other Non-Cash Items | 149.99% | 162.52% | 146.04% | 214.02% | 110.65% |
| Change in Net Operating Assets | -82.62% | -142.04% | -120.00% | -164.49% | 177.51% |
| Cash from Operations | 15.72% | 5.93% | -5.21% | 4.37% | 34.22% |
| Capital Expenditure | 48.07% | 62.14% | 65.90% | 76.64% | 11.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 227.13% |
| Cash from Investing | -101.81% | 41.62% | 51.52% | 60.65% | -82.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 49.55% | 99.82% | 100.00% |
| Issuance of Common Stock | -25.09% | 619.65% | 43.49% | -68.76% | -68.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | 334.50% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.84% | -0.84% | 94.17% | 94.17% | 94.17% |
| Cash from Financing | -85.37% | 51.20% | 251.23% | -31.76% | 1,305.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -550.41% | 59.20% | 101.44% | -300.61% | -17.47% |